Dixon Tech

A 23% rise in cost of materials to ₹15,064 crore further hit profitability. The cost pressures also affected Dixon’s operating margin, which in the June quarter took an 80 basis points (bps) hit to drop to 3% for the period.

Indian equity benchmarks opened higher due to falling crude oil prices and easing geopolitical concerns. Nifty 50 rose 0.23% to 24,044.50, while Sensex advanced 0.35% to 77,080.09, driven by a peace agreement between the US and Iran, enhancing investor sentiment.

Dixon Technologies share price rises 6.5% from the day's low, recovering from significant selling pressure since mid-November. Despite this rebound, the stock remains 32.5% below its recent peak, reflecting broader challenges in the EMS sector.

Dixon Technologies shares fell 2.5% to ₹14,585 as Phillip Capital downgraded estimates due to rising competition, particularly from Karbonn, which is increasing its share of Motorola's outsourcing. The brokerage revised Dixon's FY27 revenue estimates down by 4% amid intensifying competition.

Dividend Stocks: Dixon Technologies, NHPC, Hindalco, Gland Pharma, Torrent Pharmaceuticals and United Spirits Limited are among six key companies that declared dividends with Q4 results. Check for dividend payout details and record dates.

EMS companies reported strong December quarter results, with Dixon leading at 117% YoY revenue growth. Avalon saw a significant PAT increase of 3.6x. JM Financial remains bullish on Dixon, PG Electroplast, and Avalon, highlighting growth drivers and maintaining 'Buy' ratings on these stocks.

Shares of Dixon Technologies tumbled 14% in today's trade, dropping to ₹15,118 apiece. Analysts are divided on the stock, with Motilal Oswal maintaining a 'buy' and raising the target to ₹20,500, while Jefferies recommends 'underperform' at ₹12,600.